PHARMACIE CHAPTAL : revenue, balance sheet and financial ratios

PHARMACIE CHAPTAL is a French company founded 12 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75017), this company of category PME shows in 2020 a revenue of 796 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE CHAPTAL (SIREN 797583713)
Indicator 2023 2020 2018 2017 2016
Revenue N/C 795 752 € N/C N/C 832 438 €
Net income 34 999 € 3 183 € 8 842 € 45 171 € 18 202 €
EBITDA N/C 17 919 € N/C N/C 46 868 €
Net margin N/C 0.4% N/C N/C 2.2%

Revenue and income statement

In 2023, PHARMACIE CHAPTAL generates positive net income of 35 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 18 k€ -> 35 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

34 999 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 163%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 34%. The balance between equity and debt is satisfactory.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

163.262%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

34.43%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

74.8%

Solvency indicators evolution
PHARMACIE CHAPTAL

Sector positioning

Debt ratio
163.26 2023
2018
2020
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average +17 pts over 3 years

In 2023, the debt ratio of PHARMACIE CHAPTAL (163.26) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
34.43% 2023
2018
2020
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average -8 pts over 3 years

In 2023, the financial autonomy of PHARMACIE CHAPTAL (34.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
21.04 years 2020
2020
Q1: 1.45 years
Med: 4.71 years
Q3: 9.29 years
Watch

In 2020, the repayment capacity of PHARMACIE CHAPTAL (21.04) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 214.88. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

214.875

Liquidity indicators evolution
PHARMACIE CHAPTAL

Sector positioning

Liquidity ratio
214.88 2023
2018
2020
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Good +56 pts over 3 years

In 2023, the liquidity ratio of PHARMACIE CHAPTAL (214.88) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
12.14x 2020
2020
Q1: 0.68x
Med: 3.88x
Q3: 8.36x
Excellent

In 2020, the interest coverage of PHARMACIE CHAPTAL (12.1x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE CHAPTAL

Positioning of PHARMACIE CHAPTAL in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of PHARMACIE CHAPTAL is estimated at 412 969 € (range 251 146€ - 580 542€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
251k€ 412k€ 580k€
412 969 € Range: 251 146€ - 580 542€
NAF 5 année 2023

Valuation method used

Net Income Multiple
34 999 € × 11.8x = 412 970 €
Range: 251 147€ - 580 543€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE CHAPTAL with other companies in the same sector:

Frequently asked questions about PHARMACIE CHAPTAL

What is the revenue of PHARMACIE CHAPTAL ?

The revenue of PHARMACIE CHAPTAL in 2020 is 796 k€.

Is PHARMACIE CHAPTAL profitable?

Yes, PHARMACIE CHAPTAL generated a net profit of 35 k€ in 2023.

Where is the headquarters of PHARMACIE CHAPTAL ?

The headquarters of PHARMACIE CHAPTAL is located in PARIS (75017), in the department Paris.

Where to find the tax return of PHARMACIE CHAPTAL ?

The tax return of PHARMACIE CHAPTAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE CHAPTAL operate?

PHARMACIE CHAPTAL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.